Every year, millions of patients suffer from diseases that lack effective treatments… Share this

Set to enter hospice care, a patient with idiopathic multicentric Castleman’s disease is now in remission after treatment with a medication predicated as the top

Every Cure is excited to highlight the potential role that leucovorin (folinic acid) may play in improving verbal communication in some individuals with autism spectrum

Every Cure will leverage Google Cloud’s infrastructure and AI technologies, including Gemini 2.0, to accelerate discoveries and improve patient outcomes Share this

This support will enable Every Cure to evaluate the most promising treatments identified by its ARPA-H-funded AI platform in laboratory and clinical studies, with the

An organization scouring thousands of existing drugs to see if any can cure hard-to-treat diseases has a powerful new ally: former FDA official Janet Woodcock.

Share this

Grant Mitchell discusses Every Cure’s mission, challenges in health tech entrepreneurship, impact assessment, future innovations, and advice for aspiring entrepreneurs. Share this

Rare diseases often require innovative treatments, but not always brand-new ones. This research nonprofit deploys AI as a matchmaker between doctors and existing medications. Share

We are excited to bring you our newest patient documentary about Kaila, a rare disease patient whose life was saved thanks to a repurposed drug

The alliance will focus specifically on enhancing clinical trials and their outcomes to boost trial success rates and the efficient use of capital by drug

New Technologies Will Enable Every Cure to Bolster its Computational Drug Development, Drug Repurposing, and Clinical Trial Simulation Efforts – Uncovering More Approved Drugs to

ABC News’ Rebecca Jarvis looks at artificial intelligence’s role in the medical field and how it’s allowing doctors to expand their research and make decisions

We talk with a doctor who discovered a cure for rare diseases with the help of artificial intelligence. Share this

Every Cure was excited to announce our 3 year, 48.3M contract with ARPA-H at the White House! The ARPA-H contract is aimed to develop our

A nonprofit that seeks to repurpose approved drugs for new indications will receive more than $48 million from the U.S. Advanced Research Projects Agency for

Over the past few years, Every Cure has developed a blueprint for an AI-powered platform that can do what humans can’t — match thousands of

Every Cure, cofounded by Penn’s David Fajgenbaum, received a three-year $48 million federal contract to develop an AI tool for rare diseases. Share this

Agency backs non-profit’s agnostic approach to drug repurposing with $48.3M Share this

ABC News chief medical correspondent Dr. Jen Ashton discusses Every Cure’s AI platform that aims to match FDA-approved drugs with diseases currently lacking approved treatments.